Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000188231 | SCV000241838 | benign | not specified | 2014-12-16 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Labcorp Genetics |
RCV001078519 | SCV000651813 | likely benign | Pitt-Hopkins-like syndrome 2 | 2023-12-31 | criteria provided, single submitter | clinical testing | |
Eurofins Ntd Llc |
RCV000726803 | SCV000703158 | uncertain significance | not provided | 2016-11-22 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002426908 | SCV002727037 | likely benign | Inborn genetic diseases | 2019-09-22 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Prevention |
RCV004737291 | SCV005341591 | likely benign | NRXN1-related disorder | 2024-09-29 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |